Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth C Anderson

Showing results (411-420 of 869) with videos related to

Pageof 87
Sort By:
Blood|August 30, 2002
2-Methoxyestradiol overcomes drug resistance in multiple myeloma cellsDharminder Chauhan, Laurence Catley, Teru Hideshima, et al.
Cancer Research|July 3, 2004
In vitro and in vivo activity of the maytansinoid immunoconjugate huN901-N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine against CD56+ multiple myeloma cellsPierfrancesco Tassone, Antonella Gozzini, Victor Goldmacher, et al.
Blood|July 16, 2005
Clinical factors predictive of outcome with bortezomib in patients with relapsed, refractory multiple myelomaPaul Gerard Guy Richardson, Bart Barlogie, James Berenson, et al.
Cancer Letters|October 15, 2013
Targeting Mcl-1 for multiple myeloma (MM) therapy: drug-induced generation of Mcl-1 fragment Mcl-1(128-350) triggers MM cell death via c-Jun upregulationFengjuan Fan, Giovanni Tonon, Muhammad Hasan Bashari, et al.
Leukemia|April 10, 2019
Development and preclinical validation of a novel covalent ubiquitin receptor Rpn13 degrader in multiple myelomaYan Song, Paul M C Park, Lei Wu, et al.
Blood|May 22, 2016
A clinically relevant in vivo zebrafish model of human multiple myeloma to study preclinical therapeutic efficacyJianhong Lin, Weihong Zhang, Jian-Jun Zhao, et al.
Blood|September 27, 2003
Immunomodulatory drug costimulates T cells via the B7-CD28 pathwayRichard LeBlanc, Teru Hideshima, Laurence P Catley, et al.
Blood|November 16, 2002
CD40 induces human multiple myeloma cell migration via phosphatidylinositol 3-kinase/AKT/NF-kappa B signalingYu-Tzu Tai, Klaus Podar, Nicholas Mitsiades, et al.
British Journal of Haematology|May 30, 2018
Elotuzumab monotherapy in patients with smouldering multiple myeloma: a phase 2 studySundar Jagannath, Jacob Laubach, Ellice Wong, et al.
Blood|March 10, 2009
Biologic sequelae of I{kappa}B kinase (IKK) inhibition in multiple myeloma: therapeutic implicationsTeru Hideshima, Dharminder Chauhan, Tanyel Kiziltepe, et al.
Pageof 87

Showing results (411-420 of 869) with videos related to

Sort By:
Pageof 87
Blood|August 30, 2002
2-Methoxyestradiol overcomes drug resistance in multiple myeloma cellsDharminder Chauhan, Laurence Catley, Teru Hideshima, et al.
Cancer Research|July 3, 2004
In vitro and in vivo activity of the maytansinoid immunoconjugate huN901-N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine against CD56+ multiple myeloma cellsPierfrancesco Tassone, Antonella Gozzini, Victor Goldmacher, et al.
Blood|July 16, 2005
Clinical factors predictive of outcome with bortezomib in patients with relapsed, refractory multiple myelomaPaul Gerard Guy Richardson, Bart Barlogie, James Berenson, et al.
Cancer Letters|October 15, 2013
Targeting Mcl-1 for multiple myeloma (MM) therapy: drug-induced generation of Mcl-1 fragment Mcl-1(128-350) triggers MM cell death via c-Jun upregulationFengjuan Fan, Giovanni Tonon, Muhammad Hasan Bashari, et al.
Leukemia|April 10, 2019
Development and preclinical validation of a novel covalent ubiquitin receptor Rpn13 degrader in multiple myelomaYan Song, Paul M C Park, Lei Wu, et al.
Blood|May 22, 2016
A clinically relevant in vivo zebrafish model of human multiple myeloma to study preclinical therapeutic efficacyJianhong Lin, Weihong Zhang, Jian-Jun Zhao, et al.
Blood|September 27, 2003
Immunomodulatory drug costimulates T cells via the B7-CD28 pathwayRichard LeBlanc, Teru Hideshima, Laurence P Catley, et al.
Blood|November 16, 2002
CD40 induces human multiple myeloma cell migration via phosphatidylinositol 3-kinase/AKT/NF-kappa B signalingYu-Tzu Tai, Klaus Podar, Nicholas Mitsiades, et al.
British Journal of Haematology|May 30, 2018
Elotuzumab monotherapy in patients with smouldering multiple myeloma: a phase 2 studySundar Jagannath, Jacob Laubach, Ellice Wong, et al.
Blood|March 10, 2009
Biologic sequelae of I{kappa}B kinase (IKK) inhibition in multiple myeloma: therapeutic implicationsTeru Hideshima, Dharminder Chauhan, Tanyel Kiziltepe, et al.
Pageof 87